Three Cases of Vasoproliferative Tumor of the Retina

Purpose: Vasoproliferative tumor of the retina (VPTR) is a histologically benign lesion that can lead to visual loss due to associated complications. Herein, the authors report the clinical presentation, treatment, and prognosis of 3 VPTR cases. Case summary: Three eyes of 3 patients with VPTR were enrolled in the present study. The patients’ fundoscopic feature showed characteristic elevated lesions of the peripheral retina without previous history of ocular disease. The patients in-cluded 2 males and 1 female, with an average age of 44.7 years. Fluorescein angiography (FAG) and indocyanine green angiography (ICGA) were helpful in establishing the diagnosis of VPTR. Additionally, 1 patient underwent ultrasonography and 2 patients underwent magnetic resonance imaging (MRI). During the follow-up period, subtenon triamcinolone acetonide injection was performed for 1 patient with macular edema, and cryotherapy was performed for 1 patient with increased peripheral exudation. Conclusions: For an adequate diagnosis of VPTR, careful examination of the peripheral retina is important. In addition, FAG/ICGA and ultrasonography can be helpful in VPTR diagnosis. Furthermore, proper treatment according to each sub-set of complication during the follow-up period is recommended.

[1]  T. Lai,et al.  Photodynamic therapy with verteporfin for vasoproliferative tumour of the retina , 2010, Acta ophthalmologica.

[2]  David J. Wilson,et al.  Pars plana vitrectomy and endoresection of a retinal vasoproliferative tumor. , 2010, Archives of ophthalmology.

[3]  Dao-Yi Yu,et al.  Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion. , 2009, American journal of ophthalmology.

[4]  Young-Hoon Park,et al.  Complications and safety profile of posterior subtenon injection of triamcinolone acetonide. , 2009, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[5]  C. Shields,et al.  Iodine I 125 plaque radiotherapy for vasoproliferative tumors of the retina in 30 eyes. , 2008, Archives of ophthalmology.

[6]  M. Saldanha,et al.  Treatment of vasoproliferative tumors with photodynamic therapy. , 2008, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

[7]  B. Damato,et al.  Treatment of a vasoproliferative tumour with intravitreal bevacizumab (Avastin) , 2007, Eye.

[8]  B. Jurklies,et al.  Ruthenium-106 plaque brachytherapy for symptomatic vasoproliferative tumours of the retina , 2006, British Journal of Ophthalmology.

[9]  H. Hayashi,et al.  Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion. , 2005, American journal of ophthalmology-glaucoma.

[10]  N. Bornfeld,et al.  Vasoproliferative tumours of the retina , 2000, The British journal of ophthalmology.

[11]  W. R. Lee,et al.  Retinal vasoproliferative tumors: surgical management and histological findings. , 2000, Archives of ophthalmology.

[12]  J. V. van Meurs,et al.  Histopathology of a vasoproliferative tumor of the ocular fundus. , 1998, Retina.

[13]  C. Shields,et al.  Vasoproliferative tumors of the ocular fundus. Classification and clinical manifestations in 103 patients. , 1995, Archives of ophthalmology.

[14]  G. Sanborn,et al.  Presumed acquired retinal hemangiomas. , 1983, Ophthalmology.